DOI QR코드

DOI QR Code

유방자기공명영상에서 추가적으로 발견된 유방 병소에 대한 조영증강 초음파의 정량적 분석을 통한 진단 능력 평가와 동적 조영증강 유방 자기공명영상 결과와의 비교

Assessment of Additional MRI-Detected Breast Lesions Using the Quantitative Analysis of Contrast-Enhanced Ultrasound Scans and Its Comparability with Dynamic Contrast-Enhanced MRI Findings of the Breast

  • 이세영 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 우옥희 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 신혜선 (고려대학교 의과대학 고려대학교 구로병원 영상의학과) ;
  • 송성은 (고려대학교 의과대학 고려대학교 안암병원 영상의학과) ;
  • 조규란 (고려대학교 의과대학 고려대학교 안암병원 영상의학과) ;
  • 서보경 (고려대학교 의과대학 고려대학교 안산병원 영상의학과) ;
  • 황순영 (고려대학교 의과대학 의과학연구지원센터 고려대학교 구로병원 통계상담실)
  • Sei Young Lee (Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea University) ;
  • Ok Hee Woo (Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea University) ;
  • Hye Seon Shin (Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea University) ;
  • Sung Eun Song (Department of Radiology, Korea University Anam Hospital, College of Medicine, Korea University) ;
  • Kyu Ran Cho (Department of Radiology, Korea University Anam Hospital, College of Medicine, Korea University) ;
  • Bo Kyoung Seo (Department of Radiology, Korea University Ansan Hospital, College of Medicine, Korea University) ;
  • Soon Young Hwang (Medical Science Research Support Center, Division of Medical Statistics, Korea University Guro Hospital, College of Medicine, Korea University)
  • 투고 : 2020.06.08
  • 심사 : 2020.09.14
  • 발행 : 2021.07.01

초록

목적 자기공명영상에서 추가적으로 발견된 조영증강 병소에 대한 조영증강 초음파의 진단능력을 평가하고 조영증강 초음파의 정량 분석을 사용하여 유방 동적 조영증강 자기공명영상과 유사한 운동 패턴 결과를 얻을 수 있는지 분석하였다. 대상과 방법 단일 센터 전향적 연구로 진행하였고, 총 71개의 자기공명영상에서 추가적으로 발견된 조영증강 병소가 포함되었다. 이러한 병소에 대해 조영증강 초음파를 시행하였고 Breast Imaging-Reporting and Data System (이하 BI-RADS)에 따라 분류하였다. 그리고 모든 병소의 BI-RADS 분류를 조직학적 결과와 비교하여 조영증강 초음파의 민감도, 특이도 및 진단 정확도를 계산하였다. 조영증강 초음파와 동적 조영증강 자기공명영상의 운동 패턴사이의 일치도는 가중 카파 분석을 사용하여 평가되었다. 결과 조영증강 초음파에서 총 46개의 병소가 BI-RADS 4B, 4C, 5로 분류되었고, 25개의 병소가 BI-RADS 3, 4A로 분류되었다. 자기공명영상에서 추가적으로 발견된 조영증강 병소에 대한 조영증강 초음파의 진단 능력은 84.9%의 민감도, 94.4%의 특이도 및 97.8%의 긍정적 예측값으로 우수하였다. 총 57/71 (80%) 병소는 조영증강 초음파와 동적 조영증강 자기공명영상 운동 패턴 결과가 일치하였고 가중 카파 값 0.66으로 좋은 일치도를 나타냈다. 부분 군 분석에서 양성 병소는 우수한 일치를 보였고(가중 카파 값 = 0.84), 관내암종은 좋은 일치를 보였다(가중 카파 값 = 0.69). 결론 MRI에서 추가 검출된 유방 결절에 대한 조영증강 초음파의 진단 능력은 우수했다. 양성 및 관내암종 병소에서 동적 조영증강 자기공명영상과 조영증강 초음파의 운동 패턴 결과는 좋은 일치도를 보였다.

Purpose To assess the diagnostic performance of contrast-enhanced ultrasound (CEUS) for additional MR-detected enhancing lesions and to determine whether or not kinetic pattern results comparable to dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the breast can be obtained using the quantitative analysis of CEUS. Materials and Methods In this single-center prospective study, a total of 71 additional MR-detected breast lesions were included. CEUS examination was performed, and lesions were categorized according to the Breast Imaging-Reporting and Data System (BI-RADS). The sensitivity, specificity, and diagnostic accuracy of CEUS were calculated by comparing the BI-RADS category to the final pathology results. The degree of agreement between CEUS and DCE-MRI kinetic patterns was evaluated using weighted kappa. Results On CEUS, 46 lesions were assigned as BI-RADS category 4B, 4C, or 5, while 25 lesions category 3 or 4A. The diagnostic performance of CEUS for enhancing lesions on DCE-MRI was excellent, with 84.9% sensitivity, 94.4% specificity, and 97.8% positive predictive value. A total of 57/71 (80%) lesions had correlating kinetic patterns and showed good agreement (weighted kappa = 0.66) between CEUS and DCE-MRI. Benign lesions showed excellent agreement (weighted kappa = 0.84), and invasive ductal carcinoma (IDC) showed good agreement (weighted kappa = 0.69). Conclusion The diagnostic performance of CEUS for additional MR-detected breast lesions was excellent. Accurate kinetic pattern assessment, fairly comparable to DCE-MRI, can be obtained for benign and IDC lesions using CEUS.

키워드

참고문헌

  1. Sridharan A, Eisenbrey JR, Dave JK, Forsberg F. Quantitative nonlinear contrast-enhanced ultrasound of the breast. AJR Am J Roentgenol 2016;207:274-281
  2. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007;244:672-691
  3. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26:3248-3258
  4. Spick C, Baltzer PA. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology 2014;273:401-409
  5. Wan C, Du J, Fang H, Li F, Wang L. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis. Eur J Radiol 2012;81:e444-e450
  6. Chung YE, Kim KW. Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography 2015;34:3-18
  7. Moon WK, Im JG, Noh DY, Han MC. Nonpalpable breast lesions: evaluation with power Doppler US and a microbubble contrast agent-initial experience. Radiology 2000;217:240-246
  8. Wan CF, Du J, Fang H, Li FH, Zhu JS, Liu Q. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors. Radiology 2012;262:450-459
  9. Wang Z, Zhou Q, Liu J, Tang S, Liang X, Zhou Z, et al. Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage. Int J Clin Exp Pathol 2014;7:6985-6991
  10. Nykanen A, Arponen O, Sutela A, Vanninen R, Sudah M. Is there a role for contrast-enhanced ultrasound in the detection and biopsy of MRI only visible breast lesions? Radiol Oncol 2017;51:386-392
  11. Sun F, Cui L, Zhang L, Hao J, Gu J, Du J, et al. Intravesical contrast-enhanced ultrasound (CEUS) for the diagnosis of vesicouterine fistula (VUF): a case report. Medicine (Baltimore) 2018;97:e0478
  12. Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Eur J Radiol 2010;73:288-293
  13. Tuncbilek N, Unlu E, Karakas HM, Cakir B, Ozyilmaz F. Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance mammography. Breast J 2003;9:403-408
  14. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213-220
  15. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30
  16. Park AY, Kwon M, Woo OH, Cho KR, Park EK, Cha SH, et al. A prospective study on the value of ultrasound microflow assessment to distinguish malignant from benign solid breast masses: association between ultrasound parameters and histologic microvessel densities. Korean J Radiol 2019;20:759-772
  17. Du J, Wang L, Wan CF, Hua J, Fang H, Chen J, et al. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol 2012;81:3890-3899
  18. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007;245:684-691
  19. Mossa-Basha M, Fundaro GM, Shah BA, Ali S, Pantelic MV. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation. Radiographics 2010;30:1673-1687
  20. Mann RM, Veltman J, Huisman H, Boetes C. Comparison of enhancement characteristics between invasive lobular carcinoma and invasive ductal carcinoma. J Magn Reson Imaging 2011;34:293-300